---

2016年

In English


Yokota T, Kanakura Y. Genetic abnormalities associated with acute lymphoblastic leukemia.
Cancer Sci. 2016 Jun; 107(6): 721–725.

Kato H, Nakazawa Y, Kurokawa Y, Kashiwagi H, Morikawa Y, Morita D, Banno F, Honda S, Kanakura Y, Tomiyama Y. Human CalDAG-GEFI deficiency increases bleeding and delays αIIbβ3 activation.
Blood. 2016 Dec 8;128(23):2729-2733. Epub 2016 Sep 23.

Takamori H, Nishiura N, Masaie H, Yoshida H, Take H, Ishikawa J, Karasuno T. Effectiveness of palonosetron in prevention of CHOP induced nausea and vomiting in patients with malignant lymphoma.
Cancer Treatment and Research Communications,Volume. 9, 2016, Pages 88–91. 10.1016/j.ctarc. 2016.08.004.

Ishibashi T, Yokota T, Tanaka H, Ichii M, Sudo T, Satoh Y, Doi Y, Ueda T, Tanimura A, Hamanaka Y, Ezoe S, Shibayama H, Oritani K, Kanakura Y. ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias.
Exp Hematol. 2016 Apr;44(4):269-81.e1.

Sudo T, Yokota T, Okuzaki D, Ueda T, Ichii M, Ishibashi T, Isono T, Habuchi Y, Oritani K, Kanakura Y. Endothelial cell-selective adhesion molecule expression in hematopoietic stem/progenitor cells is essential for erythropoiesis recovery after bone marrow injury.
PLoS One. 2016 Apr 25;11(4):e0154189.

Shimomura Y, Mitsui H, Yamashita Y, Kamae T, Kanai A, Matsui H, Ishibashi T, Tanimura A, Shibayama H, Oritani K, Kuyama J, Kanakura Y. New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion.
Cancer Sci. 2016 Aug;107(8):1165-8.

Sasano T, Tomimatsu T, Nishimura J, Matsumura I, Kanakura Y, Kimura T. Two consecutive pregnancies in a patient with paroxysmal nocturnal haemoglobinuria treated with anticoagulant therapy at different doses.
Blood Coagul Fibrinolysis. 2016 Jan;27(1):109-12.

Miyasaka N, Miura O, Kawaguchi T, Arima N, Morishita E, Usuki K, Morita Y, Nishiwaki K, Ninomiya H, Gotoh A, Imashuku S, Urabe A, Shichishima T, Nishimura J, Kanakura Y. Pregnancy outcomes of patients with paroxysmal nocturnal hemoglobinuria treated with eculizumab: a Japanese experience and updated review.
Int J Hematol. 2016 Jun;103(6):703-12.

Ninomiya H, Obara N, Chiba S, Usuki K, Nishiwaki K, Matsumura I, Shichishima T, Okamoto S, Nishimura J, Ohyashiki K, Nakao S, Ando K, Kanda Y, Kawaguchi T, Nakakuma H, Harada D, Akiyama H, Kinoshita T, Ozawa K, Omine M, Kanakura Y. Interim analysis of post-marketing surveillance of eculizumab for paroxysmal nocturnal hemoglobinuria in Japan.
Int J Hematol. 2016 Nov;104(5):548-558. Epub 2016 Jul 27.

Togi S, Hatano Y, Muromoto R, Kawanishi E, Ikeda O, Hirashima K, Kon S, Kitai Y, Yasui T, Oritani K, Matsuda T. Caspase-dependent cleavage regulates protein levels of Epstein-Barr virus-derived latent membrane protein 1.
FEBS Lett. 2016 Mar;590(6):808-18.

Togi S, Muromoto R, Hirashima K, Kitai Y, Okayama T, Ikeda O, Matsumoto N, Kon S, Sekine Y, Oritani K, Matsuda T. A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3.
J Biol Chem. 2016 May 20;291(21):11161-71.

Fujita S, Kashiwagi H, Tomimatsu T, Ito S, Mimura K, Kanagawa T, Endo M, Miyoshi T, Okamura Y, Tani Y, Tomiyama Y, Kimura T. Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jr(a).
Transfusion. 2016 May;56(5):1171-81.

Kobayashi S, Ueda Y, Nannya Y, Shibayama H, Tamura H, Ogata K, Akatsuka Y, Usuki K, Ito Y, Okada M, Suzuki T, Hata T, Matsuda A, Tohyama K, Kakumoto K, Koga D, Mitani K, Naoe T, Sugiyama H, Takaku F. Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.
Cancer Biomark. 2016 Mar 31;17(1):21-32.

Mu S, Kuroda Y, Shibayama H, Hino M, Tajima T, Corrado C, Lin R, Waldron E, Binlich F, Suzuki K. Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.
Eur J Clin Pharmacol. 2016 Feb;72(2):153-61.

Watanabe T, Tobinai K, Matsumoto M, Suzuki K, Sunami K, Ishida T, Ando K, Chou T, Ozaki S, Taniwaki M, Uike N, Shibayama H, Hatake K, Izutsu K, Ishikawa T, Shumiya Y, Kashihara T, Iida S. A phase 1/2 study of carfilzomib in Japanese patients with relapsed and/or refractory multiple myeloma.
Br J Haematol. 2016 Mar;172(5):745-56.

Maruyama D, Nagai H, Fukuhara N, Kitano T, Ishikawa T, Shibayama H, Choi I, Hatake K, Uchida T,  Nishikori M, Kinoshita T, Matsuno Y, Nishikawa T, Takahara S, Tobinai K. Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma.
Cancer Sci. 2016 Dec; 107(12): 1785–1790.Published online 2016 Nov 25.

Takenaka K, Shimoda K, Uchida N, Shimomura T, Nagafuji K, Kondo T, Shibayama H, Mori T, Usuki K, Azuma T, Tsutsumi Y, Tanaka J, Dairaku H, Matsuo K, Ozawa K, Kurokawa M, Arai S, Akashi K. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.
Int J Hematol. 2017 Jan;105(1):59-69.